Figure 7.
Antigen-specific antibody production across in vitro treatments expressed as estimated means ± SEM of inhibition percentage. CON = Untreated peripheral mononuclear blood cells (PBMCs); AAPH = PBMCs treated with 3 mM of 2,2′-Azobis(2-amidinopropane) dihydrochloride (AAPH); BHV = PBMCs treated 8 × 104 TCID50 Bovine Herpesvirus 1 per 1 × 106 PBMCs; BHV-1 + AAPH = PBMCs treated 8 × 104 TCID50 Bovine Herpesvirus 1 per 1 × 106 PBMCs and 3 mM AAPH. An increase in % inhibition means an increase in the amount of anti-BHV-1 IgG. Results were compared with Tukey’s test. ** p < 0.01, **** p < 0.0001, ns: p > 0.05.